To hear about similar clinical trials, please enter your email below
Trial Title:
Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations
NCT ID:
NCT05865964
Condition:
Surgery
Conditions: Official terms:
Neoplasms
Conditions: Keywords:
Medical Care
clinical trial
innovation
breaks
surgeons
oncology
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
The field of surgery continues to benefit from innovative solutions, changing surgical
methods and techniques. Evaluation in terms of efficacy and Quality-Safety is an
essential topic that directly affects the introduction of innovations. It is essential to
carry out a robust evaluation strategy for surgical innovations, even if these are often
opposed to drug innovations. The aim of this study is to investigate the anthropological,
socio-cultural and psychological differences of surgeons that influence the evaluation of
surgical innovations.
Detailed description:
RESEARCH HYPOTHESIS Over the past decade, the role of the surgeon in scientific research
in oncology has evolved and many surgeons are involved in basic research activities
alongside their clinical activities. Despite this increasing involvement in research, the
issue of evaluation of surgical procedures remains a major concern. As an example, the
French Society of Oncological Surgery programs at its annual congress a plenary session
"Randomized trial: the grail in oncological surgery?". When the topic of clinical
research is discussed, one of the first reactions is usually to point out the differences
between research on new therapies and on surgical procedures. This persistent claim can
be challenged. This claim may also be related to the major difference in regulation
between therapeutics (MA) and medical devices (CE markings) which may not have encouraged
surgeons to develop the culture of randomised evidence.
No study seems to evaluate the factors related to the surgeon influencing his involvement
and participation in clinical research in oncological surgery. The aim of our study is to
determine which anthropo-sociological factors in surgeons are associated with the
obstacles to the evaluation of surgical innovations and influence their degree of
participation in clinical research.
OBJECTIVES OF THE STUDY The main objective of this study is to evaluate the factors
associated with the obstacles to the evaluation of surgical innovations.
The secondary objectives are :
- To identify the factors associated with involvement in clinical research on two
levels : (i) Investigator coordinator, (ii) Investigator in a study.
- To assess knowledge of complementary designs to the randomised trial.
- To identify the parameters associated with 'knowledge' of the complementary regimens
to the randomised trial.
STUDY DESIGN This is a prospective study conducted on a national scale in the form of a
survey of surgeons working in cancerology. This project has obtained the support of
UNICANCER (Federation of Cancer Centres), the French-speaking Society of Oncological
Surgery (SFCO), the Head and Neck Tumour Study Group (GETTEC), the French Society of
Cervico-facial Carcinology (SFCCF), French Society of Gynecology Oncology (SFOG), French
Association of Digestive & Visceral Surgery and the French Society of Thoracic and
Cardiovascular Surgery. Their mailings will be used to disseminate the survey to surgeons
in the area.
STUDY PROCESS
Phase 1: Questionnaire creation
The first part of the project will consist in the creation of the questionnaire. The
questionnaire will include data related to the surgeon (non-exhaustive list):
- Demography: age, gender
- Education :
- Place and date of graduation from medical school,
- Obtained DESC in oncology or European equivalent
- Practice :
- Speciality: senology, gynaecology,...
- Main place of practice: CHU, CLCC, CHG, Private clinic, ESPIC outside CLCC, Other,
- Number of treated patients per year.
- Involvement in clinical research:
- Accreditation to GCP Validated,
- Number of trials as Coordinating Investigator / Principal Investigator,
- Number of patients included in a clinical trial per year,
- Member of a learned society or cooperative group,
Questions associated with barriers to conducting trials in surgery and alternative
methodological approaches will be drafted.
Practitioners' attitudes towards risk and uncertainty will be assessed by the following
tools:
1. Questions on willingness to take risk in general and in different areas (answers
given on a scale of 0-10).
2. Questions on the willingness to engage in risky activities in different areas
(answers given on a scale of 0-10).
3. Choice of lotteries : choice between 6 lotteries characterised by different payoffs
and risk levels.
In order to check the feasibility, the online questionnaire will be evaluated by the
steering committee. The steering committee will include members from the sponsoring
centre but also external members who will not be involved in the creation of the
questionnaire. Once the questionnaire has been developed, the regulatory steps will be
taken.
Phase 2: Awareness raising In this type of study, one of the key points is the response
to the questionnaires. In order to mobilise a maximum of surgeons, actions (presentation,
Webinar) will be carried out with the different groups/companies that have agreed to
participate in the projects.
Phase 3: Sending of questionnaires The questionnaires will be sent to the different
surgeons via the Sphynx survey software. This software allows the distribution of dynamic
and interactive questionnaires with a display adapted to different media (computer,
tablet, smartphone, etc.).
STATISTICAL METHODOLOGY Number of participants needed In two previous studies with a
similar methodology, a response rate with usable questionnaires of 17 to 30% was
observed, corresponding to 200 and 230 questionnaires. With 200 usable questionnaires and
assuming that for 50% of them, obstacles to the evaluation of surgical innovations are
identified, it is possible to carry out a multivariable model with 12 parameters
according to the rule of thumb of 10 events per variable.
Statistical analysis Demographic data will be described by the usual descriptive
statistics. Categorical variables will be presented as follows: number of missing data,
number and percentage for each modality of the variable. Quantitative data will be
presented as follows: median, minimum, maximum, number of missing data.
Criteria for eligibility:
Study pop:
Surgeon practising oncology in France.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Surgeon practising oncology in France.
- E-mail address accessible via one of the companies/cooperating groups that have
agreed to participate in the project
Exclusion Criteria:
- None
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Institut Claudius Regaud
Address:
City:
Toulouse
Zip:
31059
Country:
France
Status:
Recruiting
Contact:
Last name:
Thomas Filleron, PhD
Phone:
+33(0)531155865
Email:
filleron.thomas@iuct-oncopole.fr
Contact backup:
Last name:
Morgane Marcou du Tillet de Villars
Phone:
+33(0)531155805
Start date:
December 14, 2022
Completion date:
December 13, 2024
Lead sponsor:
Agency:
Institut Claudius Regaud
Agency class:
Other
Collaborator:
Agency:
West Cancerology Institute, France
Agency class:
Other
Collaborator:
Agency:
Toulouse Capitole University
Agency class:
Other
Source:
Institut Claudius Regaud
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05865964